A Drug Regulatory Specialist serves as a key liaison between product developers and regulatory authorities, ensuring that therapeutic products comply with all applicable laws and guidelines. Their role involves compiling and submitting comprehensive documentation required for regulatory approvals, such as Investigational New Drug (IND) applications, New Drug Applications (NDA), and Marketing Authorization Applications (MAA). They carefully interpret complex regulatory requirements from agencies worldwide and provide strategic advice to align product development activities accordingly. By managing timelines and coordinating cross-functional teams, these specialists help streamline the approval process and minimize regulatory risks. Their work ensures that products meet the highest standards for safety, efficacy, and quality before reaching patients.
Beyond submissions, Drug Regulatory Specialists continuously monitor changes in regulations and guidance documents to ensure ongoing compliance throughout a product’s lifecycle. They assist in preparing responses to regulatory queries, supporting inspections and audits, and updating product information when necessary. Their expertise in navigating the global regulatory environment supports successful product launches and market access. This role demands strong communication skills, attention to detail, and the ability to adapt to evolving regulatory frameworks. Ultimately, their contributions are vital in bringing safe and effective treatments to patients while maintaining the integrity of the regulatory process.
Title : Medical liver biopsy: Toward a personalized approach
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Emerging formulation and delivery applications of vitamin E TPGS
Andreas M Papas, Antares Health Products, United States
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through design-inspired biotech- & biopharma-driven applications and upgraded business marketing to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Mathematical modeling the disc diffusion test: Antibacterial activity of copper-doped SnO2
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Genetic keys and nano locks: Unlocking personalized medicine
Srividya Narayanan, Northeastern University, United States
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico